UNLIMITED TURBO LONG - MERCK & CO. | Market Closed - Borsa Italiana 21:04:59 05/07/2024 BST | ||
| 3.41 EUR | 0.00% |
|
| Current month | -0.58% | ||
| 1 month | -8.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 3.42 | +1.79% |
| 04/07/24 | 3.36 | -2.04% |
| 03/07/24 | 3.43 | -4.46% |
| 02/07/24 | 3.59 | -0.28% |
| 01/07/24 | 3.6 | +4.65% |
Real-time Borsa Italiana
Last update July 05, 2024 at 09:04 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| P1I618 | |
| ISIN | NLBNPIT1I618 |
| Date issued | 12/10/2022 |
| Strike | 96.89 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.29 € |
|---|---|
| Lowest since issue | 1.206 € |
| Spread | 0.01 € |
| Spread % | 0.29% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4
USD
Average target price
142.7
USD
Spread / Average Target
+12.84%
- Stock Market
- Certificates
- P1I618 Certificat
